| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF007 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF457-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | R-401-C-ABS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12103-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12104-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF366-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12104 | |||
| Azide and BSA Free | NBP2-12104-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12103 | |||
| Azide and BSA Free | NBP2-12103-0.025mg | |||
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining in human lymph node and cerebral cortex tissues using anti-CCL21 antibody. Corresponding CCL21 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0006.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining in human lymph node and cerebral cortex tissues using anti-CCL21 antibody. Corresponding CCL21 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human spleen shows moderate cytoplasmic positivity in cells in red pulp.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0010.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human cerebral cortex shows low expression as expected.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0004.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human lymph node shows high expression.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0005.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human cerebral cortex shows no cytoplasmic positivity in neuronal cells as expected.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0008.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human placenta shows no cytoplasmic positivity in trophoblastic cells as expected.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0009.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human tonsil shows moderate to strong cytoplasmic positivity in germinal center cells.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0011.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (MM0146-2H26) [NBP2-12103] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase K for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-MM0146-2H26-Immunohistochemistry-Paraffin-NBP2-12103-img0001.jpg "Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (MM0146-2H26) [NBP2-12103] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase K for antige retrieval before IHC is applied.")
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (RM0174-10K10) [NBP2-12104] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP2-12104](http://images.novusbio.com/fullsize/CCL21-6Ckine-Antibody-RM0174-10K10-Immunohistochemistry-Paraffin-NBP2-12104-img0001.jpg "Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (RM0174-10K10) [NBP2-12104] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP2-12104")
![Western Blot: CCL21/6Ckine Antibody (SR1207) [NBP3-22286] - Western blot analysis using NBP3-22286 in Human CCL21/6Ckine recombinant protein lysate.](http://images.novusbio.com/fullsize/nbp3-22286_rabbit-ccl21-6ckine-mab-sr1207-5720231754889.jpg "Western Blot: CCL21/6Ckine Antibody (SR1207) [NBP3-22286] - Western blot analysis using NBP3-22286 in Human CCL21/6Ckine recombinant protein lysate.")
![Western Blot: CCL21 Overexpression Lysate (Adult Normal) [NBL1-08851] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for CCL21.](http://images.novusbio.com/fullsize/CCL21-Overexpression-Lysate-Adult-Normal-Western-Blot-NBL1-08851-img0002.jpg "Western Blot: CCL21 Overexpression Lysate (Adult Normal) [NBL1-08851] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for CCL21.")